Prognostic indicators of assisted reproduction technology outcomes of cycles with ultralow serum antimullerian hormone: a multivariate analysis of over 5,000 autologous cycles from the Society for Assisted Reproductive Technology Clinic Outcome Reporting System database for 2012-2013

摘要

Objective: To assess cycle outcomes when antimullerian hormone (AMH) is ultralow (<= 0.16 ng/mL) and to determine which parameters contribute to the probability of cycle cancellation and/or outcome.